These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 26963143

  • 1. Beta cell specific probing with fluorescent exendin-4 is progressively reduced in type 2 diabetic mouse models.
    Lehtonen J, Schäffer L, Rasch MG, Hecksher-Sørensen J, Ahnfelt-Rønne J.
    Islets; 2015; 7(6):e1137415. PubMed ID: 26963143
    [Abstract] [Full Text] [Related]

  • 2. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.
    Jin CH, Chae SY, Son S, Kim TH, Um KA, Youn YS, Lee S, Lee KC.
    J Control Release; 2009 Feb 10; 133(3):172-7. PubMed ID: 18977255
    [Abstract] [Full Text] [Related]

  • 3. Automated recognition and quantification of pancreatic islets in Zucker diabetic fatty rats treated with exendin-4.
    Kakimoto T, Kimata H, Iwasaki S, Fukunari A, Utsumi H.
    J Endocrinol; 2013 Jan 10; 216(1):13-20. PubMed ID: 23092878
    [Abstract] [Full Text] [Related]

  • 4. Puerarin Protects Pancreatic β-Cells in Obese Diabetic Mice via Activation of GLP-1R Signaling.
    Yang L, Yao D, Yang H, Wei Y, Peng Y, Ding Y, Shu L.
    Mol Endocrinol; 2016 Mar 10; 30(3):361-71. PubMed ID: 26789107
    [Abstract] [Full Text] [Related]

  • 5. Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes.
    Nielsen LL, Young AA, Parkes DG.
    Regul Pept; 2004 Feb 15; 117(2):77-88. PubMed ID: 14700743
    [Abstract] [Full Text] [Related]

  • 6. Exendin-4, a glucagon-like peptide-1 receptor agonist, suppresses pancreatic β-cell destruction induced by encephalomyocarditis virus.
    Sano H, Terasaki J, Mishiba Y, Imagawa A, Hanafusa T.
    Biochem Biophys Res Commun; 2011 Jan 21; 404(3):756-61. PubMed ID: 21144822
    [Abstract] [Full Text] [Related]

  • 7. The novel GLP-1-gastrin dual agonist, ZP3022, increases β-cell mass and prevents diabetes in db/db mice.
    Fosgerau K, Jessen L, Lind Tolborg J, Østerlund T, Schæffer Larsen K, Rolsted K, Brorson M, Jelsing J, Skovlund Ryge Neerup T.
    Diabetes Obes Metab; 2013 Jan 21; 15(1):62-71. PubMed ID: 22862961
    [Abstract] [Full Text] [Related]

  • 8. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD, Lavery KS, Irwin N, O'harte FP, Harriott P, Greer B, Bailey CJ, Flatt PR.
    J Pharmacol Exp Ther; 2006 Aug 21; 318(2):914-21. PubMed ID: 16648370
    [Abstract] [Full Text] [Related]

  • 9. The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats.
    Kaya-Dagistanli F, Ozturk M.
    Acta Histochem; 2013 Jul 21; 115(6):577-86. PubMed ID: 23351716
    [Abstract] [Full Text] [Related]

  • 10. Exendin-4 modulates diabetes onset in nonobese diabetic mice.
    Hadjiyanni I, Baggio LL, Poussier P, Drucker DJ.
    Endocrinology; 2008 Mar 21; 149(3):1338-49. PubMed ID: 18063685
    [Abstract] [Full Text] [Related]

  • 11. Exendin-4 potentiates insulinotropic action partly via increasing beta-cell proliferation and neogenesis and decreasing apoptosis in association with the attenuation of endoplasmic reticulum stress in islets of diabetic rats.
    Kwon DY, Kim YS, Ahn IS, Kim DS, Kang S, Hong SM, Park S.
    J Pharmacol Sci; 2009 Dec 21; 111(4):361-71. PubMed ID: 20019445
    [Abstract] [Full Text] [Related]

  • 12. In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor.
    Wu Z, Todorov I, Li L, Bading JR, Li Z, Nair I, Ishiyama K, Colcher D, Conti PE, Fraser SE, Shively JE, Kandeel F.
    Bioconjug Chem; 2011 Aug 17; 22(8):1587-94. PubMed ID: 21692471
    [Abstract] [Full Text] [Related]

  • 13. The effects of glucagon-like peptide-1 on the beta cell.
    Vilsbøll T.
    Diabetes Obes Metab; 2009 Dec 17; 11 Suppl 3():11-8. PubMed ID: 19878257
    [Abstract] [Full Text] [Related]

  • 14. Blocking of Glucagonlike Peptide-1 Receptors in the Exocrine Pancreas Improves Specificity for β-Cells in a Mouse Model of Type 1 Diabetes.
    Khera E, Zhang L, Roberts S, Nessler I, Sandoval D, Reiner T, Thurber GM.
    J Nucl Med; 2019 Nov 17; 60(11):1635-1641. PubMed ID: 31076502
    [Abstract] [Full Text] [Related]

  • 15. Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes.
    Campbell SA, Golec DP, Hubert M, Johnson J, Salamon N, Barr A, MacDonald PE, Philippaert K, Light PE.
    Mol Metab; 2020 Sep 17; 39():101014. PubMed ID: 32413586
    [Abstract] [Full Text] [Related]

  • 16. Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure.
    Kimura T, Obata A, Shimoda M, Hirukawa H, Kanda-Kimura Y, Nogami Y, Kohara K, Nakanishi S, Mune T, Kaku K, Kaneto H.
    Diabetes Metab; 2018 Jun 17; 44(3):250-260. PubMed ID: 29525225
    [Abstract] [Full Text] [Related]

  • 17. Incretin effect: GLP-1, GIP, DPP4.
    Kazafeos K.
    Diabetes Res Clin Pract; 2011 Aug 17; 93 Suppl 1():S32-6. PubMed ID: 21864749
    [Abstract] [Full Text] [Related]

  • 18. Activation of glucagon-like peptide-1 receptor inhibits growth and promotes apoptosis of human pancreatic cancer cells in a cAMP-dependent manner.
    Zhao H, Wei R, Wang L, Tian Q, Tao M, Ke J, Liu Y, Hou W, Zhang L, Yang J, Hong T.
    Am J Physiol Endocrinol Metab; 2014 Jun 15; 306(12):E1431-41. PubMed ID: 24801389
    [Abstract] [Full Text] [Related]

  • 19. Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
    Himeno T, Kamiya H, Naruse K, Harada N, Ozaki N, Seino Y, Shibata T, Kondo M, Kato J, Okawa T, Fukami A, Hamada Y, Inagaki N, Seino Y, Drucker DJ, Oiso Y, Nakamura J.
    Diabetes; 2011 Sep 15; 60(9):2397-406. PubMed ID: 21810596
    [Abstract] [Full Text] [Related]

  • 20. Protection of exendin-4 analogue in early experimental diabetic retinopathy.
    Zhang Y, Wang Q, Zhang J, Lei X, Xu GT, Ye W.
    Graefes Arch Clin Exp Ophthalmol; 2009 May 15; 247(5):699-706. PubMed ID: 19084986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.